Persistent URL of this record https://hdl.handle.net/1887/96180
In Collections
This item can be found in the following collections:
![Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes
- All authors
- Schouwenburg, M.G.; Jochems, A.; Leeneman, B.; Franken, M.G.; Eertwegh, A.J.M. van den; Haanen, J.B.A.G.; Zeijl, M.C.T. van; Aarts, M.J.; Akkooi, A.C.J. van; Berkmortel, F.W.P.J. van den; Blokx, W.A.M.; Groot, J.W.B. de; Hospers, G.A.P.; Kapiteijn, E.; Koornstra, R.H.; Kruit, W.H.; Louwman, M.W.J.; Piersma, D.; Rijn, R.S. van; Suijkerbuijk, K.P.M.; Tije, A.J. ten; Vreugdenhil, G.; Wouters, M.W.J.M.; Hoeven, J.J.M. van der
- Date
- 2018-08-31
- Journal
- Melanoma Research
- Volume
- 28
- Issue
- 4
- Pages
- 326 - 332